Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?
<h4>Background</h4>Randomised clinical trials (RCTs) of antiviral interventions in patients with chronic hepatitis C virus (HCV) infection use sustained virological response (SVR) as the main outcome. There is sparse information on long-term mortality from RCTs.<h4>Methods</h4&g...
Guardado en:
Autores principales: | Kurinchi S Gurusamy, Edward Wilson, Ronald L Koretz, Victoria B Allen, Brian R Davidson, Andrew K Burroughs, Christian Gluud |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5a099b96a3b746fb9bf2af1ed630f283 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
por: Chua DL, et al.
Publicado: (2014) -
Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes
por: Juliana Piedade, et al.
Publicado: (2021) -
Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.
por: Meritxell Llorens-Revull, et al.
Publicado: (2021) -
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
por: Vicente Soriano, et al.
Publicado: (2022) -
Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
por: Tseng CW, et al.
Publicado: (2016)